Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/591692


Philippines Pharmaceuticals & Healthcare Report Q3 2007


Description: The Philippines Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the Philippines pharmaceuticals and healthcare industry.

At the time of going to press, the Philippines was debating the highly controversial Cheaper Medicines Bill, which would make drugs more affordable by allowing parallel imports and reducing exclusivity periods. According to the Pharmaceutical & Healthcare Report Q3 2007, we believe that this legislation will be approved, to the great benefit of many people on low incomes. However, as can be expected, this will result in lower revenues for international drugmakers. The market is characterised by an emerging over-the-counter (OTC) sector as Filipinos increasingly self-medicate. Going forward, the author is forecasting pharmaceutical sector growth of approximately 7% through to 2011, when the market will have a valuation of US$3.4bn.

As part of measures to prevent unreasonable increases in the prices of medicines, the Senate is considering a price ceiling in September. However, the Department of Trade and Industry was against the idea as high prices were the result of an absence of healthy competition between suppliers. Moreover, the department said that creation of such control was redundant since the Price Act had already formed the National Price Coordinating Council, which monitors price movements of various commodities, including medicines.

Despite an improving economic climate, the Philippines is refusing to spend more on healthcare to bring the sector up to international standards, according to the advocacy group Health Alliance for Democracy (HEAD). This is a concern because many people with low incomes will continue to struggle for basic care, particularly basic drugs which are expensive on regional terms. The author recommends that less is spent on the military and the law on cheap pharmaceuticals is passed.

President Arroyo called upon Indian drugmakers in September 2007 to submit proposals to supply the Philippines with cheap generic medicines. Collaborations with Filipino companies was the preferred arrangement, but we believe that government purchase - through the Philippine International Trading Corporation (PITC) - may also happen. Later that month, major Indian firm Dr Reddy’s Laboratories revealed that it was penetrating the Filipino market in partnership with local firm Britton Marketing Corporation.


Contents: Executive Summary 5
Philippines Pharmaceutical & Healthcare Industry SWOT 6
Philippines Political SWOT 7
Philippines Economic SWOT 7
Philippines Business Environment SWOT 8
The Philippines: Business Environment Ranking 9
Table: Asia Business Environment Rankings 9
Business Environment Ranking 10
Economics - Long-Term Risk 10
Politics - Long-Term Risk 10
Regulatory Barriers 10
Domestic Sector Threat 10
Market Growth Potential 11
Market Size Ranking 11
The Philippines: Market Summary 12
Regulatory Regime14
Intellectual Property Regime 15
IP Shortcomings 16
IP Disputes 17
Counterfeit Drugs 17
Pricing & Reimbursement Regime 18
Parallel Trade 20
Corruption 20
International Co-operation 20
Industry Trends & Developments22
Epidemiological Trends 22
Healthcare Sector 23
Medical Tourism 25
Pharmaceutical Sector 25
Table Clinical Trial Considerations In Asia 26
Domestic Industry 26
Foreign Companies 26
Traditional Medicines 27
Pharmaceutical Retail 28
Industry Forecast Scenario 30
Overall Market Forecast 30
Table: Philippines Pharmaceuticals Market Trends 31
Key Growth Factors - Industry 32
Table: Philippines Health Expenditure Forecasts 33
Key Growth Factors - Macroeconomic 34
Table: Philippines - Economic Activity 36
Prescription Market Forecast 37
Table: Philippines Prescription Drugs Market Indicators 38
OTC Market Forecast 39
Table: Philippines OTC Drugs Market Indicators 40
Generics And Branded Market Forecast 41
Table: Philippines Generics And Branded Market Forecasts 42
Export/Import Forecasts 43
Table: Philippines Pharmaceuticals Exports & Imports Forecasts 44
Other Healthcare Data Forecasts 45
Table: Philippines Other Health Indicators 45
Key Risks To our Forecast Scenario 46
Competitive Landscape47
Company Monitor48
Profiles: Leading Multinational Manufacturers 48
GlaxoSmithKline Philippines 48
Pfizer 51
Novartis 53
Merck & Co 55
Sanofi-Aventis 57
Abbott Laboratories 58
Bristol-Myers Squibb 59
Wyeth 61
Eli Lilly 63
Indigenous Manufacturers 64
Unilab 64
Pascual Laboratories 67
Pacific Pharmaceuticals 69
MediChem Pharmaceuticals 70
BMI Forecast Modelling71
How We Generate Our Industry Forecasts 71
Technical Process 71
Pharmaceutical Industry 72


Companies Mentioned - Abbott Laboratories - Bristol-Myers Squibb - Eli Lilly - MediChem Pharmaceuticals - Merck & Co - Novartis - Pacific Pharmaceuticals - Pascual Laboratories - Pfizer - Sanofi-Aventis - Unilab - Wyeth.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/591692

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 12/02/2012 23:34:43
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Philippines Pharmaceuticals & Healthcare Report Q3 2007
Web Address:
http://www.researchandmarkets.com/reports/591692
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €398.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 12/02/2012 23:34:43

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)